ES2103756T3 - Deteccion de metabolizadores ineficaces de farmacos. - Google Patents
Deteccion de metabolizadores ineficaces de farmacos.Info
- Publication number
- ES2103756T3 ES2103756T3 ES91108867T ES91108867T ES2103756T3 ES 2103756 T3 ES2103756 T3 ES 2103756T3 ES 91108867 T ES91108867 T ES 91108867T ES 91108867 T ES91108867 T ES 91108867T ES 2103756 T3 ES2103756 T3 ES 2103756T3
- Authority
- ES
- Spain
- Prior art keywords
- detection
- metabolizers
- ineffective
- pharmaceutical
- responsible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Abstract
UN METODO PARA LA DETECCION DE METABOLIZANTES POBRES DE DROGAS UTILIZANDO TECNOLOGIA PCR COMO SE DESCRIBE INCLUYENDO A) AMPLIFICAR OPCIONALMENTE UNA CODIFICACION DE GEN PARA UNA ENZIMA DE LA QUE SE SABE QUE ES RESPONSABLE DE LA METABOLIZACION DE MEDICAMENTOS, SEPARANDOLA DE ESTE MODO DE SEUDOGENES RELACIONADOS POSIBLEMENTE CERCANOS, B) AMPLIFICAR DIFERENTES FORMAS ALELICAS DEL GEN DEL PASO A) Y C) DETECTAR EL PRODUCTO DEL PASO B). TAMBIEN SE DESCRIBEN LOS ELEMENTOS PRIMARIOS PARA LA AMPLIACION DE GENES QUE CODIFICAN LAS ENZIMAS METABOLIZANTES DE DROGAS, ESPECIALMENTE LOS GENES QUE CODIFICAN LAS ENZIMAS RESPONSABLES DE DEBRISOQUINA O ACETILACION FENOTIPO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP90810467 | 1990-06-22 | ||
EP91108867A EP0463395B1 (en) | 1990-06-22 | 1991-05-29 | Detection of poor metabolizers of drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2103756T3 true ES2103756T3 (es) | 1997-10-01 |
Family
ID=26127843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91108867T Expired - Lifetime ES2103756T3 (es) | 1990-06-22 | 1991-05-29 | Deteccion de metabolizadores ineficaces de farmacos. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5648482A (es) |
EP (1) | EP0463395B1 (es) |
JP (1) | JP3372044B2 (es) |
AU (1) | AU645091B2 (es) |
CA (1) | CA2045012C (es) |
DE (1) | DE69126064T2 (es) |
ES (1) | ES2103756T3 (es) |
NZ (1) | NZ238610A (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9001181D0 (en) * | 1990-01-18 | 1990-03-21 | Imp Cancer Res Tech | Genetic assay |
JPH05260980A (ja) * | 1992-03-23 | 1993-10-12 | Tokyo Met Gov Shinkei Kagaku Sogo Kenkyusho | ヒト・アリルアミンn−アセチル転移酵素遺伝子 |
US5912120A (en) * | 1992-04-09 | 1999-06-15 | The United States Of America As Represented By The Department Of Health And Human Services, | Cloning, expression and diagnosis of human cytochrome P450 2C19: the principal determinant of s-mephenytoin metabolism |
US7115364B1 (en) | 1993-10-26 | 2006-10-03 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US20060229824A1 (en) | 1993-10-26 | 2006-10-12 | Affymetrix, Inc. | Arrays of nucleic acid probes for analyzing biotransformation genes |
US6306348B1 (en) * | 1993-11-01 | 2001-10-23 | Nanogen, Inc. | Inorganic permeation layer for micro-electric device |
JP3564579B2 (ja) * | 1994-05-06 | 2004-09-15 | 大塚製薬株式会社 | ヒトチトクロームp4502d6遺伝子多型の検出方法 |
US5643723A (en) * | 1994-05-26 | 1997-07-01 | Roche Molecular Systems, Inc. | Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens |
US5719026A (en) * | 1994-07-06 | 1998-02-17 | Otsuka Pharmaceutical Co., Ltd. | Method for detecting polymorphism of human cytochrome P4501A2 gene |
US6048734A (en) | 1995-09-15 | 2000-04-11 | The Regents Of The University Of Michigan | Thermal microvalves in a fluid flow method |
US6391550B1 (en) | 1996-09-19 | 2002-05-21 | Affymetrix, Inc. | Identification of molecular sequence signatures and methods involving the same |
US6183963B1 (en) * | 1998-10-23 | 2001-02-06 | Signalgene | Detection of CYP1A1, CYP3A4, CYP2D6 and NAT2 variants by PCR-allele-specific oligonucleotide (ASO) assay |
US7135283B1 (en) * | 1998-11-17 | 2006-11-14 | Nanogen, Inc. | Topoisomerase type II gene polymorphisms and their use in identifying drug resistance and pathogenic strains of microorganisms |
GB9828619D0 (en) | 1998-12-23 | 1999-02-17 | Janssen Pharmaceutica Nv | An assay for genotyping cytochrome expression |
WO2001001218A2 (en) * | 1999-06-25 | 2001-01-04 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
US7058517B1 (en) | 1999-06-25 | 2006-06-06 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
AU7730500A (en) * | 1999-09-30 | 2001-04-30 | Nanogen, Inc. | Biomolecular attachment sites on microelectronic arrays and methods thereof |
US6303082B1 (en) * | 1999-12-15 | 2001-10-16 | Nanogen, Inc. | Permeation layer attachment chemistry and method |
US7250252B2 (en) | 1999-12-30 | 2007-07-31 | David Aaron Katz | Amplification based polymorphism detection |
JP2004500816A (ja) * | 2000-01-14 | 2004-01-15 | インサイト・ゲノミックス・インコーポレイテッド | 薬剤代謝酵素 |
AU2001235000A1 (en) * | 2000-02-11 | 2001-08-20 | Incyte Genomics, Inc. | Drug metabolizing enzymes |
EP1272638A2 (en) * | 2000-04-13 | 2003-01-08 | Incyte Genomics, Inc. | Drug metabolizing enzymes |
US7229756B1 (en) | 2000-10-19 | 2007-06-12 | University Of Cincinnati | Alpha-2B-adrenergic receptor polymorphisms |
WO2001079561A2 (en) * | 2000-04-17 | 2001-10-25 | Liggett Stephen B | Alpha-2 adrenergic receptor polymorphisms |
US6931326B1 (en) | 2000-06-26 | 2005-08-16 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
US7211386B2 (en) * | 2000-08-10 | 2007-05-01 | University Of Cincinnati | Alpha-2A-adrenergic receptor polymorphisms |
GB0021286D0 (en) * | 2000-08-30 | 2000-10-18 | Gemini Genomics Ab | Identification of drug metabolic capacity |
US20040167065A1 (en) * | 2000-09-29 | 2004-08-26 | Lal Preeti G. | Transferases |
EP1395656A2 (en) * | 2000-09-29 | 2004-03-10 | Incyte Genomics, Inc. | Human drug metabolizing enzymes |
US7054758B2 (en) * | 2001-01-30 | 2006-05-30 | Sciona Limited | Computer-assisted means for assessing lifestyle risk factors |
EP1339879A4 (en) * | 2001-06-05 | 2004-12-29 | Genaissance Pharmaceuticals | METHOD OF IDENTIFYING POLYMORPHISM IN CYP2D6 |
DE60232523D1 (de) * | 2001-07-26 | 2009-07-16 | Stratagene California | Multi-stellen-mutagenese |
US6960298B2 (en) | 2001-12-10 | 2005-11-01 | Nanogen, Inc. | Mesoporous permeation layers for use on active electronic matrix devices |
US20040267458A1 (en) * | 2001-12-21 | 2004-12-30 | Judson Richard S. | Methods for obtaining and using haplotype data |
US20040096874A1 (en) * | 2002-04-11 | 2004-05-20 | Third Wave Technologies, Inc. | Characterization of CYP 2D6 genotypes |
US20040091909A1 (en) * | 2002-07-05 | 2004-05-13 | Huang Doug Hui | High throughput cytochrome P450 genotyping |
US8394944B2 (en) * | 2002-09-20 | 2013-03-12 | Siemens Healthcare Diagnostics Inc. | Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation |
US8688385B2 (en) | 2003-02-20 | 2014-04-01 | Mayo Foundation For Medical Education And Research | Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype |
WO2004094986A2 (en) * | 2003-04-16 | 2004-11-04 | Handylab, Inc. | System and method for electrochemical detection of biological compounds |
US20050032781A1 (en) * | 2003-08-06 | 2005-02-10 | Elliot Ehrich | Methods for administering active agents to CYP 2D6 sensitive patients |
AU2005259787B2 (en) * | 2004-06-30 | 2011-02-24 | Luminex Molecular Diagnostics, Inc. | Method of detecting mutations in the gene encoding cytochrome P450-2D6 |
DE602005021525D1 (de) | 2004-09-14 | 2010-07-08 | Univ Colorado | R behandlung mit bucindolol |
US7572586B2 (en) * | 2005-11-01 | 2009-08-11 | Mayo Foundation For Medical Education And Research | Identifying susceptibility to cardiac hypertrophy |
EP1958111A4 (en) * | 2005-11-29 | 2009-07-08 | Childrens Hosp Medical Center | OPTIMIZATION AND PERSONALIZATION OF SELECTION AND DOSAGE OF DRUGS |
US7687103B2 (en) * | 2006-08-31 | 2010-03-30 | Gamida For Life B.V. | Compositions and methods for preserving permeation layers for use on active electronic matrix devices |
WO2008076856A2 (en) * | 2006-12-14 | 2008-06-26 | Siemens Healthcare Diagnostics Inc. | Reagents and methods for detecting cyp2d6 polymorphisms |
EP2468278A1 (en) | 2007-05-04 | 2012-06-27 | Cardiome Pharma Corp. | Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia |
CN102876775A (zh) * | 2012-05-03 | 2013-01-16 | 骆子义 | 用实时荧光定量pcr检测nat2基因多态性的试剂盒及方法 |
CN114317533B (zh) * | 2022-01-12 | 2023-08-29 | 武汉艾迪康医学检验所有限公司 | 一组探针和利用杂交捕获法检测药物基因组学相关基因cyp2d6多态性的建库试剂盒 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US292815A (en) * | 1884-02-05 | William hofeb | ||
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
CA1338457C (en) * | 1986-08-22 | 1996-07-16 | Henry A. Erlich | Purified thermostable enzyme |
CA1317535C (en) * | 1987-06-30 | 1993-05-11 | Nanibhushan Dattagupta | Assay of sequences using amplified genes |
IE61148B1 (en) * | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
US5508199A (en) * | 1989-01-03 | 1996-04-16 | The United States Of America As Represented By The Department Of Health And Human Services | P450db1 clones for identifying humans with genetic defect in drug metabolism |
-
1991
- 1991-05-29 DE DE69126064T patent/DE69126064T2/de not_active Revoked
- 1991-05-29 ES ES91108867T patent/ES2103756T3/es not_active Expired - Lifetime
- 1991-05-29 EP EP91108867A patent/EP0463395B1/en not_active Revoked
- 1991-06-18 AU AU78487/91A patent/AU645091B2/en not_active Expired
- 1991-06-19 CA CA002045012A patent/CA2045012C/en not_active Expired - Lifetime
- 1991-06-19 NZ NZ238610A patent/NZ238610A/xx unknown
- 1991-06-21 JP JP15069291A patent/JP3372044B2/ja not_active Expired - Lifetime
-
1994
- 1994-03-02 US US08/204,697 patent/US5648482A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3372044B2 (ja) | 2003-01-27 |
DE69126064D1 (de) | 1997-06-19 |
EP0463395B1 (en) | 1997-05-14 |
CA2045012C (en) | 2005-10-18 |
JPH05211895A (ja) | 1993-08-24 |
EP0463395A1 (en) | 1992-01-02 |
AU7848791A (en) | 1992-01-02 |
CA2045012A1 (en) | 1991-12-23 |
US5648482A (en) | 1997-07-15 |
NZ238610A (en) | 1993-11-25 |
AU645091B2 (en) | 1994-01-06 |
DE69126064T2 (de) | 1997-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2103756T3 (es) | Deteccion de metabolizadores ineficaces de farmacos. | |
GEP20094601B (en) | Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes | |
ATE545709T1 (de) | Nachweis von polymorphismen mittels amplifikation | |
FI934849A0 (fi) | Sammansaettningar foer foerhindrande och/eller behandlande av patologiskaprocesser | |
ES2194468T3 (es) | Uso de derivados del bisindol indigoide para la fabricacion de un medicamento para inhibir quinasas dependientes de ciclinas. | |
DK0693924T4 (da) | Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil | |
AU1634092A (en) | Vaccines and methods for their production | |
WO2002103011A3 (en) | Selective gene amplification | |
CA960211A (en) | PROCESS FOR THE PREPARATION OF NEW .alpha.-AMINOPENICILLINS AND SUCH PENICILLINS, AND INTERMEDIATES AND PHARMACEUTICAL PREPARATIONS | |
IT8719615A0 (it) | Procedimento per la protezione di sistanze poco stabili con mischele polimeriche e processi per la loro applicazione. | |
ES2167748T3 (es) | Derivados del polisacarido k5 con actividad anticoagulante. | |
HUP0203295A2 (hu) | Emphysema kezelése RAR-szelektív retinoid agonistákat tartalmazó gyógyszerkészítmények felhasználásával | |
ES2114525T3 (es) | Uso de cebadores oligonucleotidicos conservados para la amplificacion de las secuencias de adn del virus de papiloma humano. | |
ATE334670T1 (de) | Verwendung von mek-inhibitoren zur herstellung eines arzneimittels gegen negativstrang-rna-viren infektionen | |
IT8468235A1 (it) | Nuovi derivati di 3-benzilidene-canfora, procedimento per la loro preparazione e loro impiego come agenti protettivi contro i raggi UV e come farmaci. | |
ES2073483T3 (es) | Derivados del cromano. | |
ES2148164T3 (es) | Cepa atenuada de vacuna del virus del sarampion, que contiene una secuencia nucleotidica especifica y procedimiento para su identificacion. | |
ES417305A1 (es) | Procedimiento para la preparacion de composiciones estabi- lizadas. | |
Neil et al. | Studies of the biochemical pharmacology of the fermentation-derived antitumor agent,(αS, 5S)-α-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (AT-125) | |
IT1209548B (it) | Derivati di acido poliidrossibenzoico ad azione farmaceutica. | |
WO2001032919A3 (de) | Gruppe von neuen primerpaaren zur pcr-amplifizierung, primerpaare, gensonden und verfahren zum nachweis von gentechnisch verändertem pflanzenmaterial | |
Akaishi | Comparison of insertion, deletion, and point mutations in the genomes of human adenovirus HAdvC-2 and SARS-CoV-2 | |
PE20220692A1 (es) | Buje de la cadena de acero con alto contenido de carbono | |
AP1623A (en) | A method of diagnosing of prognosticating HIV infection in a subject. | |
GB1343119A (en) | Flavone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 463395 Country of ref document: ES |